Using fluorescent in situ hybridization (FISH) analysis in another independent cohort of MDS/AML samples, we found that the RPL22 locus was more frequently deleted in progenitor cells from both patients with MDS and with AML (Figure 1I). Here, RPL22 is linked to myelodysplastic syndrome.